MELBOURNE, Australia & MENLO PARK, Calif.--(BUSINESS WIRE)--ChemGenex Pharmaceuticals Limited (ASX:CXS) and (NASDAQ:CXSP) today announced that at the company’s Annual General Meeting yesterday it received shareholder approval for the demerger of its metabolic diseases business, Autogen Research Limited, which is to be renamed Verva Pharmaceuticals Limited.
